Serge Saxonov is Chief Executive Officer of 10x Genomics, Inc.. Currently has a direct ownership of 882,467 shares of TXG, which is worth approximately $20.3 Million. The most recent transaction as insider was on Oct 05, 2021, when has been sold 8,668 shares (Class A Common Stock) at a price of $8.26 per share, resulting in proceeds of $71,598. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 882K
0.76% 3M change
2.74% 12M change
Total Value Held $20.3 Million

Serge Saxonov Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 05 2021
BUY
Exercise of conversion of derivative security
$71,598 $8.26 p/Share
8,668 Added 0.95%
907,136 Class A Common Stock
Sep 07 2021
SELL
Open market or private sale
$2,820,150 $188.01 p/Share
15,000 Reduced 1.64%
898,468 Class A Common Stock
Sep 07 2021
BUY
Exercise of conversion of derivative security
$123,900 $8.26 p/Share
15,000 Added 1.62%
913,468 Class A Common Stock
Aug 23 2021
SELL
Open market or private sale
$120,093 $161.85 p/Share
742 Reduced 0.08%
903,326 Class A Common Stock
Aug 03 2021
SELL
Open market or private sale
$2,669,700 $177.98 p/Share
15,000 Reduced 1.63%
904,068 Class A Common Stock
Aug 03 2021
BUY
Exercise of conversion of derivative security
$123,900 $8.26 p/Share
15,000 Added 1.61%
919,068 Class A Common Stock
Jul 06 2021
SELL
Open market or private sale
$2,904,750 $193.65 p/Share
15,000 Reduced 1.63%
904,068 Class A Common Stock
Jul 06 2021
BUY
Exercise of conversion of derivative security
$123,900 $8.26 p/Share
15,000 Added 1.61%
919,068 Class A Common Stock
Jun 08 2021
SELL
Open market or private sale
$2,789,850 $185.99 p/Share
15,000 Reduced 1.63%
904,068 Class A Common Stock
Jun 08 2021
BUY
Exercise of conversion of derivative security
$123,900 $8.26 p/Share
15,000 Added 1.61%
919,068 Class A Common Stock
Jun 04 2021
SELL
Bona fide gift
-
200 Reduced 0.02%
904,068 Class A Common Stock
May 24 2021
SELL
Open market or private sale
$125,411 $162.66 p/Share
771 Reduced 0.09%
904,268 Class A Common Stock
May 04 2021
SELL
Open market or private sale
$2,760,900 $184.06 p/Share
15,000 Reduced 1.68%
880,468 Class A Common Stock
May 04 2021
BUY
Exercise of conversion of derivative security
$123,900 $8.26 p/Share
15,000 Added 1.65%
895,468 Class A Common Stock
Apr 06 2021
SELL
Open market or private sale
$2,931,600 $195.44 p/Share
15,000 Reduced 1.68%
880,468 Class A Common Stock
Apr 06 2021
BUY
Exercise of conversion of derivative security
$123,900 $8.26 p/Share
15,000 Added 1.65%
895,468 Class A Common Stock
Mar 19 2021
BUY
Grant, award, or other acquisition
-
24,571 Added 2.64%
905,039 Class A Common Stock
Mar 12 2021
SELL
Open market or private sale
$2,353,350 $156.89 p/Share
15,000 Reduced 1.68%
880,468 Class A Common Stock
Mar 12 2021
BUY
Exercise of conversion of derivative security
$123,900 $8.26 p/Share
15,000 Added 1.65%
895,468 Class A Common Stock
Feb 01 2021
SELL
Open market or private sale
$1,765,400 $176.54 p/Share
10,000 Reduced 1.12%
880,468 Class A Common Stock
Feb 01 2021
BUY
Exercise of conversion of derivative security
$82,600 $8.26 p/Share
10,000 Added 1.11%
890,468 Class A Common Stock
Jan 04 2021
SELL
Open market or private sale
$1,404,300 $140.43 p/Share
10,000 Reduced 1.12%
880,468 Class A Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
$50,400 $5.04 p/Share
10,000 Added 1.11%
890,468 Class A Common Stock
Dec 22 2020
BUY
Exercise of conversion of derivative security
$4,137 $1.14 p/Share
3,629 Added 0.41%
880,468 Class A Common Stock
Dec 14 2020
BUY
Bona fide gift
-
15,000 Added 1.68%
876,839 Class A Common Stock
SS

Serge Saxonov

Chief Executive Officer
Pleasanton, CA

Track Institutional and Insider Activities on TXG

Follow 10x Genomics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG